Accufit Muscle Activation Decreases Abdominal Fat Layer

Ultrasound imaging showed an increase in abdominal muscle thickness with a decrease in the abdominal fat layer for most patients.

The majority of subjects had fat loss and an increase in abdominal muscle thickness following treatment with the Accufit.
The majority of subjects had fat loss and an increase in abdominal muscle thickness following treatment with the Accufit.

A pilot study, published in the Journal of Drugs in Dermatology (October 2021), sought to assess the efficacy and safety of a novel bioelectric muscle activation device for muscle toning and fat reduction.

Researchers William LoVerme, MD, and Glen Calderhead, MSc, PhD, assessed the outcomes of 29 subjects who underwent four 30-minute treatments with Lutronic’s Bioelectric Muscle Activation (BMA) system, Accufit, which employs unique waveforms and proprietary electrodes to enable various muscle contractions while minimizing discomfort.

Related: EMMS Treatment Offers High Patient Satisfaction

Outcomes were assessed using clinical photography, weight, abdominal circumference measurements and ultrasound images recorded at baseline and 30 days post-final treatment.

Of the 29 subjects, 14 were very satisfied, 13 were satisfied, one was neutral and one was dissatisfied. Ninety-seven percent responded that they would recommend the treatment. The most common comfort-related concerns reported included a tingling sensation and mild pressure during treatment.

Related: Combination Contouring Treatments

Independent randomized expert photography grading correctly identified the treated versus the baseline images with a concordance rating of >90%. Ultrasound imaging showed an increase in abdominal muscle thickness with a decrease in the abdominal fat layer for most patients.

Based on the results of the pilot study, the authors concluded that further studies with larger populations are warranted.

More in Devices